Technology

Latest News

May 17th 2024

Putting LP-284 on the Industry RADR

By Miranda Schmalfuhs

Panna Sharma, CEO of Lantern Pharma, discusses LP-284, using their RADR during testing, ensuring global use, and what the future holds.

Conference Calls for Unity in Addressing Artificial Intelligence Regulation in Life Sciences Research and Development

By Don Tracy, Associate Editor

Image credit: NicoElNino | stock.adobe.com

April 29th 2024

AI in Clinical Trials: The Future of Drug Discovery

By Nancy Kapila

Latest Videos

Breaking Down Data Silos to Enable Real-Time Trial Oversight

Breaking Down Data Silos to Enable Real-Time Trial Oversight

Using Digital Twins to Improve Efficiency and Accuracy in Clinical Research

Using Digital Twins to Improve Efficiency and Accuracy in Clinical Research

How Integrated Systems Help Biotechs Stay Inspection-Ready

How Integrated Systems Help Biotechs Stay Inspection-Ready

How Remote Monitoring Enhances Trial Efficiency and Patient Safety

How Remote Monitoring Enhances Trial Efficiency and Patient Safety

Adapting to a Changing Research Funding Landscape

Adapting to a Changing Research Funding Landscape

What Clinical Ops Teams Must Know About Biomarkers in Trials

What Clinical Ops Teams Must Know About Biomarkers in Trials

How Biomarkers Are Transforming Neurology and Oncology Trials

How Biomarkers Are Transforming Neurology and Oncology Trials

Growing Excitement Around Biomarkers in Clinical Trials

Growing Excitement Around Biomarkers in Clinical Trials

Building Clinical Trial Infrastructure Inside Pharmacies

Building Clinical Trial Infrastructure Inside Pharmacies

AI Levels the Playing Field in Trial Recruitment

AI Levels the Playing Field in Trial Recruitment

More News

Trending on Applied Clinical Trials Online

AI Is Moving Faster Than Any Technology Before It

ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway